Advertisement
Screener

CHEMED CORPORATION (CHE) Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount

CHEMED CORPORATION Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount

CHEMED CORPORATION (CHE) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $19.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-07-31

  • CHEMED CORPORATION effective income tax rate reconciliation at federal statutory income tax rate, amount for the quarter ending 2026-06-30 was $19.18M, a 28.43% increase year-over-year.
  • CHEMED CORPORATION effective income tax rate reconciliation at federal statutory income tax rate, amount for the quarter ending 2025-06-30 was $14.93M.
  • CHEMED CORPORATION effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was $74.71M, a 10.94% decline from fiscal 2024.
  • CHEMED CORPORATION effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $83.89M, a 14.01% increase from fiscal 2023.
  • CHEMED CORPORATION effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $73.58M, a 6.27% increase from fiscal 2022.
  • CHEMED CORPORATION effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was $69.23M, a 5.89% decline from fiscal 2021.
Period endEffective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 3 monthEffective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 6 monthEffective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month
2026-06-30$19.18M
10-Q · filed 2026-07-31
$37.84M
10-Q · filed 2026-07-31
2025-12-31$74.71M
10-K · filed 2026-02-27
2025-06-30$14.93M
10-Q · filed 2026-07-31
$35.03M
10-Q · filed 2026-07-31
2024-12-31$83.89M
10-K · filed 2026-02-27
2023-12-31$73.58M
10-K · filed 2026-02-27
2022-12-31$69.23M
10-K · filed 2025-02-28
2021-12-31$73.57M
10-K · filed 2024-02-29
2020-12-31$83.16M
10-K · filed 2023-02-27
2019-12-31$54.94M
10-K · filed 2022-02-28
2018-12-31$50.32M
10-K · filed 2021-02-26
2017-12-31$40.92M
10-K · filed 2020-02-26
2016-12-31$61.97M
10-K · filed 2019-02-27
2015-12-31$63.04M
10-K · filed 2018-02-26
2014-12-31$56.96M
10-K · filed 2017-02-27
2013-12-31$43.34M
10-K · filed 2016-02-26
2012-12-31$51.04M
10-K · filed 2015-02-27
2011-12-31$49.20M
10-K · filed 2014-02-27
2010-12-31$46.84M
10-K · filed 2013-02-27
2009-12-31$42.22M
10-K · filed 2012-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Option Care Health, Inc. (OPCH)United States$3.602B20.52
Aveanna Healthcare Holdings, Inc. (AVAH)United States$2.703B7.22
Addus HomeCare Corp (ADUS)United States$2.129B17.80
BrightSpring Health Services, Inc. (BTSG)United States$11.078B37.65
AdaptHealth Corp. (AHCO)United States$0.759B-6.22